These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8128417)

  • 1. [Analysis of bioequivalence trials. From analysis to statistic trials].
    Houin G
    Therapie; 1993; 48(4):289-95. PubMed ID: 8128417
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage form performance: a major factor in clinical medicine.
    Dittert LW
    Conn Med; 1976 May; 40(5):333-7. PubMed ID: 776529
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of bioequivalence].
    Aoyagi N
    Eisei Shikenjo Hokoku; 1996; (114):141-2. PubMed ID: 9037886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Glasser AC
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):449-52. PubMed ID: 3683019
    [No Abstract]   [Full Text] [Related]  

  • 7. On testing for bioequivalence.
    Rocke DM
    Biometrics; 1984 Mar; 40(1):225-30. PubMed ID: 6547355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.
    Shah VP; Flynn GL; Yacobi A; Maibach HI; Bon C; Fleischer NM; Franz TJ; Kaplan SA; Kawamoto J; Lesko LJ; Marty JP; Pershing LK; Schaefer H; Sequeira JA; Shrivastava SP; Wilkin J; Williams RL
    Pharm Res; 1998 Feb; 15(2):167-71. PubMed ID: 9523299
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bioequivalence of dosage forms. The confidence interval approach. Westlake's method (author's transl)].
    Steimer JL; Thebault JJ
    Therapie; 1980; 35(6):743-7. PubMed ID: 7233364
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical evaluation of physiological variability of rifampicin in fixed dose combinations.
    Panchagnula R; Parmar J; Kaur K; Singh I; Bade SR; Ashokraj Y
    Int J Pharm; 2006 Apr; 313(1-2):5-13. PubMed ID: 16517107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harmonization of testing drugs for bioequivalence: problems and possible solutions].
    Zherdev VP; Kolyvanov GB; Litvin AA; Sariev AK
    Eksp Klin Farmakol; 2003; 66(2):60-4. PubMed ID: 12962051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veterinary drug bioequivalence determination.
    Toutain PL; Koritz GD
    J Vet Pharmacol Ther; 1997 Apr; 20(2):79-90. PubMed ID: 9131533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review and use of decision rules for bioequivalence trials].
    Nicolas P; Tod M; Petitjean O
    Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. FDA Individual Bioequivalence Working Group.
    Hauck WW; Chen ML; Hyslop T; Patnaik R; Schuirmann D; Williams R
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):535-41. PubMed ID: 8996848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
    Liao JJ
    Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals.
    Esinhart JD; Chinchilli VM
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):26-32. PubMed ID: 8199749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian modeling of multivariate average bioequivalence.
    Ghosh P; Gönen M
    Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination for the two one-sided tests procedure in bioequivalence.
    Liu JP; Chow SC
    J Pharmacokinet Biopharm; 1992 Feb; 20(1):101-4. PubMed ID: 1588502
    [No Abstract]   [Full Text] [Related]  

  • 19. [What model for pharmacokinetic analysis of tissue distribution and bioequivalence?].
    Marzo A; Monti NC
    Boll Chim Farm; 1998 Mar; 137(3):69-73. PubMed ID: 9611844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statistical tests for bioequivalence].
    Peil H; Häselbarth V
    Arzneimittelforschung; 1985; 35(10):1489-94. PubMed ID: 4074402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.